← Insider buys
DCPH

Deciphera Pharmaceuticals, Inc.

Director Michael Douglas Taylor sold $1.4M of Deciphera Pharmaceuticals, Inc.

Sold$1,422,490
$56.90Price
25,000Shares
−100%Stake

What DCPH did after the filing

Prices for DCPH after this filing aren't in yet.

Traded Tue, Apr 28. Filed Thu, Apr 30, 12:05 PM ET, during the session. Not investment advice.